Etienne J Du Preez1, Kenneth S Graham, Thomas Y Gan, Bassam Moses, Chris Ball, Donald E Kuah. 1. *Australasian College of Sport and Exercise Physicians, Sydney, Australia; †Applied Research Program, New South Wales Institute of Sport, Sydney, Australia; ‡Narrabeen Sports Medicine Centre, Sydney, Australia; §Southern Cross Orthopaedic and Sports Clinic, Sydney, Australia; ¶Sports Clinic NQ, North Ward, Australia; and ‖Sydney Sports Medicine Centre, New South Wales Institute of Sport, Sydney, Australia.
Abstract
OBJECTIVE: To assess the prevalence of symptoms of depression, anxiety, and rates of alcohol misuse in elite rugby league players in Australasia. DESIGN: A cross-sectional, epidemiological study with repeated measures. SETTING: Surveys were conducted during the 2015 preseason and in-season. PARTICIPANTS: Four hundred four elite rugby league players participated preseason and 278 players in-season. MAIN OUTCOME MEASURES: Symptoms of depression were measured using the Patient Health Questionnaire-9 scale, symptoms of generalized anxiety disorder (GAD) with the GAD-7 scale, and the Alcohol Use Disorders Identification Test Consumption scale was used to assess hazardous alcohol use. RESULTS: The overall prevalence of depression was 12.6% preseason and 10.1% in-season. Generalized anxiety disorder had a prevalence of 14.6% and 10.1% for these 2 periods. Overall, 68.6% of players had hazardous levels of alcohol use preseason, and 62.8% in-season. There was no significant difference for any of the main outcomes between the periods. Players with a history of mental illnesses had 5.62 greater odds (95% confidence interval [CI], 2.62-12.04) of depression than those without during preseason, and 22.08 greater odds (95% CI, 7.77-62.71) in-season. Players reporting ≥3 previous concussions had 2.02 greater odds (95% CI, 1.07-3.82) of depression than those reporting ≤2 in the preseason sample. CONCLUSIONS: Rugby league players have a lower prevalence of depression compared with studies of the general population and other athletes, but a higher prevalence of GAD, and high rates of alcohol misuse. Clubs may consider implementing regular screening for these conditions. Further prospective research to determine causality of independent factors is required.
OBJECTIVE: To assess the prevalence of symptoms of depression, anxiety, and rates of alcohol misuse in elite rugby league players in Australasia. DESIGN: A cross-sectional, epidemiological study with repeated measures. SETTING: Surveys were conducted during the 2015 preseason and in-season. PARTICIPANTS: Four hundred four elite rugby league players participated preseason and 278 players in-season. MAIN OUTCOME MEASURES: Symptoms of depression were measured using the Patient Health Questionnaire-9 scale, symptoms of generalized anxiety disorder (GAD) with the GAD-7 scale, and the Alcohol Use Disorders Identification Test Consumption scale was used to assess hazardous alcohol use. RESULTS: The overall prevalence of depression was 12.6% preseason and 10.1% in-season. Generalized anxiety disorder had a prevalence of 14.6% and 10.1% for these 2 periods. Overall, 68.6% of players had hazardous levels of alcohol use preseason, and 62.8% in-season. There was no significant difference for any of the main outcomes between the periods. Players with a history of mental illnesses had 5.62 greater odds (95% confidence interval [CI], 2.62-12.04) of depression than those without during preseason, and 22.08 greater odds (95% CI, 7.77-62.71) in-season. Players reporting ≥3 previous concussions had 2.02 greater odds (95% CI, 1.07-3.82) of depression than those reporting ≤2 in the preseason sample. CONCLUSIONS: Rugby league players have a lower prevalence of depression compared with studies of the general population and other athletes, but a higher prevalence of GAD, and high rates of alcohol misuse. Clubs may consider implementing regular screening for these conditions. Further prospective research to determine causality of independent factors is required.
Authors: Vita Pilkington; Simon M Rice; Courtney C Walton; Kate Gwyther; Lisa Olive; Matt Butterworth; Matti Clements; Gemma Cross; Rosemary Purcell Journal: Sports Med Open Date: 2022-07-06
Authors: Eugene M Dunne; Catherine W Striley; Zachary L Mannes; Breton M Asken; Nicole Ennis; Linda B Cottler Journal: Clin J Sport Med Date: 2020-11 Impact factor: 3.454
Authors: Simon M Rice; Kate Gwyther; Olga Santesteban-Echarri; David Baron; Paul Gorczynski; Vincent Gouttebarge; Claudia L Reardon; Mary E Hitchcock; Brian Hainline; Rosemary Purcell Journal: Br J Sports Med Date: 2019-06 Impact factor: 13.800
Authors: Vincent Gouttebarge; João Mauricio Castaldelli-Maia; Paul Gorczynski; Brian Hainline; Mary E Hitchcock; Gino M Kerkhoffs; Simon M Rice; Claudia L Reardon Journal: Br J Sports Med Date: 2019-06 Impact factor: 13.800
Authors: Sarah Ann Harris; Paola T Chivers; Fleur L McIntyre; Ben Piggott; Max Bulsara; Fiona H Farringdon Journal: BMJ Open Sport Exerc Med Date: 2020-03-08